155 related articles for article (PubMed ID: 29367687)
21. Prognostic values of Ki-67 in neoadjuvant setting for breast cancer: a systematic review and meta-analysis.
Li L; Han D; Wang X; Wang Q; Tian J; Yao J; Yuan L; Qian K; Zou Q; Yi W; Zhou E; Yang K
Future Oncol; 2017 May; 13(11):1021-1034. PubMed ID: 28088868
[TBL] [Abstract][Full Text] [Related]
22. Randomized study of preoperative chemotherapy versus primary surgery for stage IB cervical cancer.
Cai HB; Chen HZ; Yin HH
J Obstet Gynaecol Res; 2006 Jun; 32(3):315-23. PubMed ID: 16764623
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of neoadjuvant chemotherapy in patients with FIGO stage IB1 to IIA cervical cancer: an international collaborative meta-analysis.
Kim HS; Sardi JE; Katsumata N; Ryu HS; Nam JH; Chung HH; Park NH; Song YS; Behtash N; Kamura T; Cai HB; Kim JW
Eur J Surg Oncol; 2013 Feb; 39(2):115-24. PubMed ID: 23084091
[TBL] [Abstract][Full Text] [Related]
24. Pattern of failures and clinical outcome of patients with locally advanced cervical cancer treated with a tailored integrated therapeutic approach.
Gadducci A; Fabrini MG; Perrone F; Manfredi B; Fanucchi A; Laliscia C; Barsotti C; Scotti V; Genazzani AR; Greco C
Anticancer Res; 2010 Sep; 30(9):3731-5. PubMed ID: 20944162
[TBL] [Abstract][Full Text] [Related]
25. Intratumoral heterogeneity in
Molina-García D; García-Vicente AM; Pérez-Beteta J; Amo-Salas M; Martínez-González A; Tello-Galán MJ; Soriano-Castrejón Á; Pérez-García VM
Ann Nucl Med; 2018 Jul; 32(6):379-388. PubMed ID: 29869770
[TBL] [Abstract][Full Text] [Related]
26. Power Doppler vascularity index for predicting the response of neoadjuvant chemotherapy in cervical carcinoma.
Chen CA; Cheng WF; Lee CN; Su YN; Hsieh CY; Hsieh FJ
Acta Obstet Gynecol Scand; 2004 Jun; 83(6):591-7. PubMed ID: 15144343
[TBL] [Abstract][Full Text] [Related]
27. Pretreatment platelet and hemoglobin levels are neither predictive nor prognostic variables for patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: a retrospective Italian study.
Gadducci A; Cosio S; Zola P; Tisi G; Ferrero A; Piovano E; Cristofani R; Greco C; Sartori E
Int J Gynecol Cancer; 2010 Nov; 20(8):1399-404. PubMed ID: 21051984
[TBL] [Abstract][Full Text] [Related]
28. Oncological outcome of complete response after neoadjuvant chemotherapy for breast conserving surgery: a systematic review and meta-analysis.
Li X; Dai D; Chen B; Tang H; Wei W
World J Surg Oncol; 2017 Nov; 15(1):210. PubMed ID: 29183336
[TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant chemotherapy in cervical cancer: an update.
Lapresa M; Parma G; Portuesi R; Colombo N
Expert Rev Anticancer Ther; 2015; 15(10):1171-81. PubMed ID: 26402247
[TBL] [Abstract][Full Text] [Related]
30. Predictive role of galectin-1 and integrin α5β1 in cisplatin-based neoadjuvant chemotherapy of bulky squamous cervical cancer.
Zhu H; Chen A; Li S; Tao X; Sheng B; Chetry M; Zhu X
Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28842515
[TBL] [Abstract][Full Text] [Related]
31. The role of neoadjuvant chemotherapy for resectable colorectal liver metastases: a systematic review and meta-analysis.
Liu W; Zhou JG; Sun Y; Zhang L; Xing BC
Oncotarget; 2016 Jun; 7(24):37277-37287. PubMed ID: 27074564
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of responsiveness of neoadjuvant chemotherapy before surgery for patients with stage IB(2)/IIA(2) cervical cancer.
Li R; Lu ST; Si JG; Liu B; Wang H; Mei YY; Linghu H
Gynecol Oncol; 2013 Mar; 128(3):524-9. PubMed ID: 23146686
[TBL] [Abstract][Full Text] [Related]
33. [Neoadjuvant chemotherapy before radiotherapy in treatment of patients with cervical carcinoma].
Li QS; Zhang XQ; Li DP; Sheng XG; Du XL; Song QQ
Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):83-7. PubMed ID: 16640853
[TBL] [Abstract][Full Text] [Related]
34. Neo-adjuvant chemotherapy plus surgery versus surgery alone for cervical cancer: Meta-analysis of randomized controlled trials.
Peng YH; Wang XX; Zhu JS; Gao L
J Obstet Gynaecol Res; 2016 Feb; 42(2):128-35. PubMed ID: 26807961
[TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant Chemotherapy Followed by Chemoradiation in Cervical Carcinoma: A Review.
de Azevedo CR; Thuler LC; de Mello MJ; Ferreira CG
Int J Gynecol Cancer; 2016 May; 26(4):729-36. PubMed ID: 26905327
[TBL] [Abstract][Full Text] [Related]
36. Clinical efficacy of modified preoperative neoadjuvant chemotherapy in the treatment of locally advanced (stage IB2 to IIB) cervical cancer: randomized study.
Chen H; Liang C; Zhang L; Huang S; Wu X
Gynecol Oncol; 2008 Sep; 110(3):308-15. PubMed ID: 18606439
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous changes of magnetic resonance diffusion-weighted imaging and pathological microstructure in locally advanced cervical cancer caused by neoadjuvant chemotherapy.
Fu C; Feng X; Bian D; Zhao Y; Fang X; Du W; Wang L; Wang X
J Magn Reson Imaging; 2015 Aug; 42(2):427-35. PubMed ID: 25328994
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant cisplatin chemotherapy before chemoradiation: a flawed paradigm?
Glynne-Jones R; Hoskin P
J Clin Oncol; 2007 Nov; 25(33):5281-6. PubMed ID: 18024876
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of pathological response to neoadjuvant chemotherapy in bulky stage Ib2 and IIa cervical squamous cell cancer patients.
Liang Y; Lü B; Chen X; Qin J; Cheng X; Xie X; Lü W
Virchows Arch; 2016 Mar; 468(3):329-36. PubMed ID: 26637198
[TBL] [Abstract][Full Text] [Related]
40. Long-Term Clinical Benefits of Neoadjuvant Chemotherapy in Women With Locally Advanced Cervical Cancer: Validity of Pathological Response as Surrogate Endpoint of Survival.
Buda A; Lissoni AA; Floriani I; Biagioli E; Gerardi C; Bonazzi C; Chiari S; Locatelli L; Dell'Anna T; Signorelli M; Mangioni C; Milani R
Int J Gynecol Cancer; 2015 Oct; 25(8):1468-75. PubMed ID: 26222484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
